Annual Cash & Cash Equivalents
$56.49 M
-$103.22 M-64.63%
December 31, 2024
Summary
- As of March 14, 2025, ACET annual cash & cash equivalents is $56.49 million, with the most recent change of -$103.22 million (-64.63%) on December 31, 2024.
- During the last 3 years, ACET annual cash & cash equivalents has fallen by -$221.05 million (-79.64%).
- ACET annual cash & cash equivalents is now -79.64% below its all-time high of $277.54 million, reached on December 31, 2021.
Performance
ACET Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$56.49 M
-$48.99 M-46.44%
December 31, 2024
Summary
- As of March 14, 2025, ACET quarterly cash and cash equivalents is $56.49 million, with the most recent change of -$48.99 million (-46.44%) on December 31, 2024.
- Over the past year, ACET quarterly cash and cash equivalents has dropped by -$48.99 million (-46.44%).
- ACET quarterly cash and cash equivalents is now -80.01% below its all-time high of $282.68 million, reached on September 30, 2022.
Performance
ACET Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACET Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.6% | -46.4% |
| 3 y3 years | -79.6% | -69.2% |
| 5 y5 years | +432.6% | -69.2% |
ACET Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.6% | at low | -80.0% | at low |
| 5 y | 5-year | -79.6% | +432.6% | -80.0% | +432.6% |
| alltime | all time | -79.6% | +3430.9% | -80.0% | +432.6% |
Adicet Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $56.49 M(-64.6%) | $56.49 M(-46.4%) |
| Sep 2024 | - | $105.48 M(-52.9%) |
| Jun 2024 | - | $224.07 M(-9.5%) |
| Mar 2024 | - | $247.59 M(+55.0%) |
| Dec 2023 | $159.71 M(-38.0%) | $159.71 M(-12.8%) |
| Sep 2023 | - | $183.26 M(-10.8%) |
| Jun 2023 | - | $205.46 M(-11.3%) |
| Mar 2023 | - | $231.64 M(-10.1%) |
| Dec 2022 | $257.66 M(-7.2%) | $257.66 M(-8.9%) |
| Sep 2022 | - | $282.68 M(+8.5%) |
| Jun 2022 | - | $260.64 M(-6.2%) |
| Mar 2022 | - | $277.88 M(+0.1%) |
| Dec 2021 | $277.54 M(+229.1%) | $277.54 M(+44.4%) |
| Sep 2021 | - | $192.23 M(-7.9%) |
| Jun 2021 | - | $208.73 M(-5.8%) |
| Mar 2021 | - | $221.67 M(+162.9%) |
| Dec 2020 | $84.33 M(+695.0%) | $84.33 M(-0.7%) |
| Sep 2020 | - | $84.96 M(+701.0%) |
| Dec 2019 | $10.61 M(-89.5%) | $10.61 M |
| Jun 2018 | $100.87 M(+81.2%) | - |
| Jun 2017 | $55.68 M(-16.7%) | - |
| Jun 2016 | $66.83 M(+96.4%) | - |
| Jun 2015 | $34.02 M(-20.7%) | - |
| Jun 2014 | $42.90 M(+29.1%) | - |
| Jun 2013 | $33.23 M(+33.7%) | - |
| Jun 2012 | $24.86 M(-13.3%) | - |
| Jun 2011 | $28.66 M(-7.1%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | $30.85 M(-46.6%) | - |
| Jun 2009 | $57.76 M(+24.2%) | - |
| Jun 2008 | $46.52 M(+43.9%) | - |
| Jun 2007 | $32.32 M(-4.2%) | - |
| Jun 2006 | $33.73 M(+69.1%) | - |
| Jun 2005 | $19.95 M(-14.5%) | - |
| Jun 2004 | $23.33 M(+15.1%) | - |
| Jun 2003 | $20.26 M(+42.1%) | - |
| Jun 2002 | $14.26 M(+95.0%) | - |
| Jun 2001 | $7.31 M(+160.0%) | - |
| Jun 2000 | $2.81 M(-29.7%) | - |
| Jun 1999 | $4.00 M(-56.5%) | - |
| Jun 1998 | $9.20 M(+124.4%) | - |
| Jun 1997 | $4.10 M(-24.1%) | - |
| Jun 1996 | $5.40 M(+237.5%) | - |
| Jun 1995 | $1.60 M(-68.6%) | - |
| Jun 1994 | $5.10 M(-8.9%) | - |
| Jun 1993 | $5.60 M(-32.5%) | - |
| Jun 1992 | $8.30 M(-26.5%) | - |
| Jun 1991 | $11.30 M(-42.6%) | - |
| Jun 1990 | $19.70 M(-14.0%) | - |
| Jun 1989 | $22.90 M(-3.4%) | - |
| Jun 1988 | $23.70 M(-11.9%) | - |
| Jun 1987 | $26.90 M(+28.7%) | - |
| Jun 1986 | $20.90 M(0.0%) | - |
| Jun 1985 | $20.90 M(+27.4%) | - |
| Jun 1984 | $16.40 M | - |
FAQ
- What is Adicet Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Adicet Bio?
- What is Adicet Bio annual cash & cash equivalents year-on-year change?
- What is Adicet Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Adicet Bio?
- What is Adicet Bio quarterly cash and cash equivalents year-on-year change?
What is Adicet Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of ACET is $56.49 M
What is the all time high annual cash & cash equivalents for Adicet Bio?
Adicet Bio all-time high annual cash & cash equivalents is $277.54 M
What is Adicet Bio annual cash & cash equivalents year-on-year change?
Over the past year, ACET annual cash & cash equivalents has changed by -$103.22 M (-64.63%)
What is Adicet Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACET is $56.49 M
What is the all time high quarterly cash and cash equivalents for Adicet Bio?
Adicet Bio all-time high quarterly cash and cash equivalents is $282.68 M
What is Adicet Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, ACET quarterly cash and cash equivalents has changed by -$48.99 M (-46.44%)